Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126171961 | 12617196 | 1 | I | 20160721 | 20160803 | 20160803 | EXP | US-ZYDUS-011750 | ZYDUS PHARM | SAN GABRIEL MC, EDDULA-CHANGALA B, TAN Y, LONGSHORE CT. ELECTROCONVULSIVE IN A SCHIZOPHRENIC PATIENT WITH NEUROLEPTIC MALIGNANT SYNDROME AND RHABDOMYOLYSIS. J-ECT 2015;31(3):197-200. | 42.00 | YR | M | Y | 0.00000 | 20160803 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126171961 | 12617196 | 1 | PS | VALPROIC ACID. | VALPROIC ACID | 1 | Unknown | 500 MG OF VALPROIC ACID AT BEDTIME | U | UNKNOWN | 78239 | 500 | MG | ||||||
| 126171961 | 12617196 | 2 | SS | HALOPERIDOL. | HALOPERIDOL | 1 | Oral | Y | UNKNOWN | 77580 | 5 | MG | |||||||
| 126171961 | 12617196 | 3 | SS | OLANZAPINE. | OLANZAPINE | 1 | Unknown | Y | UNKNOWN | 0 | 20 | MG | |||||||
| 126171961 | 12617196 | 4 | SS | CLONAZEPAM. | CLONAZEPAM | 1 | Unknown | Y | UNKNOWN | 0 | 1 | MG | TID | ||||||
| 126171961 | 12617196 | 5 | SS | LORAZEPAM. | LORAZEPAM | 1 | Oral | U | UNKNOWN | 0 | 2 | MG | |||||||
| 126171961 | 12617196 | 6 | SS | CHLORPROMAZINE. | CHLORPROMAZINE | 1 | Intramuscular | Y | UNKNOWN | 0 | 100 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126171961 | 12617196 | 1 | Product used for unknown indication |
| 126171961 | 12617196 | 2 | Product used for unknown indication |
| 126171961 | 12617196 | 3 | Schizoaffective disorder depressive type |
| 126171961 | 12617196 | 4 | Product used for unknown indication |
| 126171961 | 12617196 | 5 | Product used for unknown indication |
| 126171961 | 12617196 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126171961 | 12617196 | LT |
| 126171961 | 12617196 | OT |
| 126171961 | 12617196 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126171961 | 12617196 | Abnormal behaviour | |
| 126171961 | 12617196 | Affect lability | |
| 126171961 | 12617196 | Aggression | |
| 126171961 | 12617196 | Blood creatine phosphokinase increased | |
| 126171961 | 12617196 | Depressive symptom | |
| 126171961 | 12617196 | Insomnia | |
| 126171961 | 12617196 | Leukocytosis | |
| 126171961 | 12617196 | Neuroleptic malignant syndrome | |
| 126171961 | 12617196 | Paranoia | |
| 126171961 | 12617196 | Pyrexia | |
| 126171961 | 12617196 | Social avoidant behaviour | |
| 126171961 | 12617196 | Tachycardia | |
| 126171961 | 12617196 | Treatment noncompliance |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |